NCT05036148View on ClinicalTrials.gov

Malignant Hyperthermia in Czech Republic: Description of the Biggest Slavonic Group of Patients Investigated for Risk of Malignant Hyperthermia

CompletedOBSERVATIONAL

Enrollment

286

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions

Malignant Hyperthermia

Interventions

OTHER

Data analysis

MH registry data will be screened for MH positive diagnosis

Trial Locations (1)

62500

Brno University Hospital - Academic Centre for Malignant Hyperthermia of Masaryk University Brno, Brno

All Listed Sponsors

collaborator

Masaryk University

OTHER

lead

Brno University Hospital

OTHER

NCT05036148 - Malignant Hyperthermia in Czech Republic: Description of the Biggest Slavonic Group of Patients Investigated for Risk of Malignant Hyperthermia | Biotech Hunter | Biotech Hunter